Genetic drift in populations governed by a Galton-Watson branching process.

Most population genetics studies have their origins in a Wright-Fisher or some closely related fixed-population model in which each individual randomly chooses its ancestor. Populations which vary in size with time are typically modelled via a coalescent derived from Wright-Fisher, but use a nonlinear time-scaling driven by a deterministically imposed population growth. An alternate, arguably more realistic approach, and one which we take here, is to allow the population size to vary stochastically via a Galton-Watson branching process.

Mitomycin C-treated antigen-presenting cells as a tool for control of allograft rejection and autoimmunity: from bench to bedside.

Cells have been previously used in experimental models for tolerance induction in organ transplantation and autoimmune diseases. One problem with the therapeutic use of cells is standardization of their preparation. We discuss an immunosuppressive strategy relying on cells irreversibly transformed by a chemotherapeutic drug.

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites.

Indoleamine 2,3-dioxygenase (IDO), an enzyme involved in the catabolism of tryptophan, is expressed in certain cells and tissues, particularly in antigen-presenting cells of lymphoid organs and in the placenta. It was shown that IDO prevents rejection of the fetus during pregnancy, probably by inhibiting alloreactive T cells, and it was suggested that IDO-expression in antigen-presenting cells may control autoreactive immune responses. Degradation of tryptophan, an essential amino acid required for cell proliferation, was reported to be the mechanism of IDO-induced T cell suppression.